This epidemiological analysis examines the application of disease registries for investigating rare cancer occurrences, focusing on population-based surveillance systems and their utility in clinical research. The study explores how electronic health records and SEER data provide comprehensive demographic and medical information for accurate disease diagnosis and monitoring. Key ethical and legal considerations are addressed, including informed consent protocols, patient confidentiality requirements, and responsible data usage in real-world clinical applications.
v
If I investigate rare cancer in Lynchburg, the Disease registries would be a great place to start from. The population-based data such as cultural background, age, sex, etc., are available to assist in surveillance, epidemiology, and result (SEER) determination. They are a type of electronic health records (EHRs) for different populations with varying health characteristics, in which cancer can be counted1. Getting hands-on with this clinical database would mean that individual patients’ health details and benefits could be gauged closely to diagnose a critical illness more accurately, like cancer2. The state, local and national jurisdictions can be conveniently accessed in which medical histories of each individual are recorded with a predefined uniform procedure for gaining particular outcomes.
In terms of legal considerations that I should keep in mind while utilizing this data, I should inform the patient whose data is to be used and ensure that their information would be kept confidential. In terms of ethical considerations, I would again let the subjects know how their information would be used and that they have the right to say ‘no’ for their medical information to be used. Informed consent and confidentiality have to be taken seriously when real-world data (RWD) like electronic health records and disease registries are collected3. Since this data can be collected easily from any access such as smartphones, laptops, biosensors, and electronic wearables, keeping privacy for the patients becomes a major concern for them and medical professionals. Their responsible use can generate positive clinical outcomes, especially for cancer patients, since basic demographic data is involved. Disease severity and genetic characteristics have to be mentioned alongside the patient’s data that give rise to legal and ethical challenges in the medical field.
You’re 74% through this paper. Sign up to read the full paper.
Sign Up Now — Instant Access Already a member? Log inAlways verify citation format against your institution’s current style guide requirements.